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ABSTRACT Mycofactocin (MFT) belongs to the class of ribosomally synthesized and
posttranslationally modiﬁed peptides conserved in many Actinobacteria. Mycobacte-
rium tuberculosis assimilates cholesterol during chronic infection, and its in vitro
growth in the presence of cholesterol requires most of the MFT biosynthesis genes
(mftA, mftB, mftC, mftD, mftE, and mftF), although the reasons for this requirement
remain unclear. To identify the function of MFT, we characterized MFT biosynthesis
mutants constructed in Mycobacterium smegmatis, M. marinum, and M. tuberculosis.
We found that the growth deﬁcit of mft deletion mutants in medium containing
cholesterol—a phenotypic basis for gene essentiality prediction—depends on etha-
nol, a solvent used to solubilize cholesterol. Furthermore, functionality of MFT was
strictly required for growth of free-living mycobacteria in ethanol and other primary
alcohols. Among other genes encoding predicted MFT-associated dehydroge-
nases, MSMEG_6242 was indispensable for M. smegmatis ethanol assimilation,
suggesting that it is a candidate catalytic interactor with MFT. Despite being a poor
growth substrate, ethanol treatment resulted in a reductive cellular state with NADH
accumulation in M. tuberculosis. During ethanol treatment, mftC mutant expressed
the transcriptional signatures that are characteristic of respirational dysfunction and
a redox-imbalanced cellular state. Counterintuitively, there were no differences in
cellular bioenergetics and redox parameters in mftC mutant cells treated with etha-
nol. Therefore, further understanding of the function of MFT in ethanol metabolism
is required to identify the cause of growth retardation of MFT mutants in choles-
terol. Nevertheless, our results establish the physiological role of MFT and also pro-
vide new insights into the speciﬁc functions of MFT homologs in other actinobacte-
rial systems.
IMPORTANCE Tuberculosis is caused by Mycobacterium tuberculosis, and the increas-
ing emergence of multidrug-resistant strains renders current treatment options inef-
fective. Although new antimycobacterial drugs are urgently required, their successful
development often relies on complete understanding of the metabolic pathways—
e.g., cholesterol assimilation—that are critical for persistence and for pathogenesis of
M. tuberculosis. In this regard, mycofactocin (MFT) function appears to be important
because its biosynthesis genes are predicted to be essential for M. tuberculosis in
vitro growth in cholesterol. In determining the metabolic basis of this genetic re-
quirement, our results unexpectedly revealed the essential function of MFT in etha-
nol metabolism. The metabolic dysfunction thereof was found to affect the myco-
bacterial growth in cholesterol which is solubilized by ethanol. This knowledge is
fundamental in recognizing the bona ﬁde function of MFT, which likely resembles
the pyrroloquinoline quinone-dependent ethanol oxidation in acetic acid bacteria
exploited for industrial production of vinegar.
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Ribosomally synthesized and posttranslationally modiﬁed peptides (RiPPs) are agroup of structurally distinct and functionally diverse natural products (1, 2), which
include mycofactocin (MFT), resembling pyrroloquinoline quinone (PQQ) cofactor and
bacteriocin (3). MFT biosynthesis appears to be conserved in many Actinobacteria,
including Mycobacterium tuberculosis, the causative agent of human tuberculosis,
which remains a global health threat (4). MFT biosynthesis is predicted to comprise a
six-gene ensemble (mft genes): mftA and mftB encode the precursor peptide and its
chaperone, respectively, and mftC, mftD, mftE, and mftF encode products that modify
MftA or are functionally associated with the MftA-derived end product(s) or both (3)
(Fig. 1). In recent years, the catalytic roles of MftC and MftE in the initial steps of MFT
synthesis have been elucidated (5–9). Moreover, the possibility of identifying novel
MFT-derived metabolite/s has been suggested, with the synthesis of these metabolites
probably involving extensive posttranslational modiﬁcation, in a stepwise or concerted
action, similar to other RiPPs (1–3, 5–9).
RiPPs share many structural and enzymatic similarities with nonribosomal peptides
(NRPs), except for the polyketide-derived moieties that are ubiquitous in NRPs (10).
Exochelin and mycobactin are notable mycobacterial NRPs which are vital for iron
acquisition and pathogenesis of M. tuberculosis (11, 12). Unlike NRPs, the signiﬁcance of
RiPPs such as MFT in mycobacteria is still elusive, although MFT is predicted to function
as a cofactor, similar to PQQ, for its nicotinoprotein redox partners (3, 13). PQQ is a
redox cofactor that supports the functions of several quinoproteins, including ethanol
(EtOH) and aldehyde dehydrogenases catalyzing the oxidation of ethanol to acetic acid
with acetaldehyde as a reaction intermediate (14–18). Besides the possibility of acting
as an analog of PQQ and catalyzing ethanol oxidation in mycobacteria, MFT could have
other cellular functions: (i) products encoded by mft genes have been suggested to be
part of the electron transport chain, which is vital forM. tuberculosis survival under both
replicating and nonreplicating conditions (19); (ii) independent saturated transposon
mutagenesis studies (20, 21) have predicted the essentiality of most of the mft genes
for in vitro growth in cholesterol—solubilized in ethanol—a carbon source required for
host adaptation of M. tuberculosis during infection (22–24). While data from the studies
mentioned above strongly imply the role of MFT in M. tuberculosis pathogenesis, the
precise nature of the biochemical function of MFT in M. tuberculosis metabolism,
particularly in cholesterol catabolism, remains unclear. Accordingly, exploring the
conditions under which mft genes are essential for in vitro growth of M. tuberculosis in
cholesterol could uncover the bona ﬁde function(s) of MFT. Consequently, insights into
the MFT-associated pathway(s) for potential therapeutic intervention could be pro-
vided and could light shed on the functions of MFT homologs conserved in many other
bacterial species.
In this study, using genetic and transcriptomic methods, we revealed that the
essentiality of mft genes for growth in cholesterol is dependent on the presence of
ethanol in M. smegmatis, M. marinum, and M. tuberculosis. We showed further that
disruption of mft genes affects the mycobacterial growth in ethanol. These ﬁndings
have implications for respiration and redox regulation during mycobacterial growth/
adaptation in ethanol.
RESULTS
MFT gene essentiality for M. smegmatis growth in cholesterol is ethanol
dependent. To determine the essentiality of mft genes for the growth of M. smegmatis
in cholesterol, single in-frame deletion mutants of all mft genes (mft mutants) were
constructed and characterized (see Fig. S1 in the supplemental material; see also
Table S1 in the supplemental material). As expected, none of the mft mutants—except
strain ΔmftE, which exhibited delayed growth—grew in minimal medium containing
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cholesterol (0.01% [wt/vol]) as the sole carbon source with hot ethanol (1% [vol/vol]) as
the solvent (cholesterol and EtOH [cholesterol:EtOH]) (Fig. 2A). In contrast, the growth
rates of all strains in glycerol-supplemented medium were comparable (Fig. S2A). Given
the key role of MftC in the initial steps of MFT biosynthesis (3, 5–9) and the near-
identical phenotypes of mft mutants, the ΔmftC strain was chosen for further analyses.
Genetic complementation of strain ΔmftC with a full-length copy of mftC at the attB
site, referred to as strain ΔmftC-Comp, reversed the growth defect, albeit with a delay,
in cholesterol:EtOH. Thus, disruption of any of the mft genes resulted in impaired
growth of M. smegmatis in cholesterol:EtOH. Subsequently, to interrogate whether the
growth limitation of strain ΔmftC was ethanol dependent, the growth of strain ΔmftC
FIG 1 Genomic organization of mft genes in M. tuberculosis H37Rv and M. smegmatis mc2155. The
schematic illustration (not drawn to scale) presents the gene names corresponding to the following mft
ortholog locus numbers and functional annotations: mftA, Rv0691A/MSMEG_1421, precursor peptide;
mftB, Rv0692/MSMEG_1422, MftA chaperone; mftC, Rv0693/MSMEG_1423, radical S-adenosylmethionine
maturase; mftD, Rv0694/MSMEG_1424, ﬂavin/heme dehydrogenase; mftE, Rv0695/MSMEG_1425, creati-
nine aminohydrolase family protein; mftF, Rv0696/MSMEG_1426, glycosyltransferase. mftB, mftC, mftD,
mftE, and mftF are identiﬁed as essential for M. tuberculosis in vitro growth in cholesterol (20, 21).
FIG 2 Ethanol limits the growth of mft mutants in medium containing cholesterol. (A) Growth of mft
mutants and wild-type (WT) strains in liquid medium containing ethanol (1% [vol/vol])-solubilized 0.01%
cholesterol (Cholesterol:EtOH) as the sole carbon source. Growth was monitored by measuring absor-
bance at 600 nm (reported as OD600). Data are representative of results from two independent experi-
ments. (B) CFU were enumerated from growth in medium containing cholesterol:EtOH or cholesterol:
DMSO (solubilized in hot DMSO). Respective solvent controls were included. Total numbers of CFU per
milliliter (means standard deviations) were determined from four independent experiments performed
in duplicate. Data presented in this panel were chosen to indicate altered growth rates of bacterial strains
during the late-exponential-growth phase (at 72 h). Bacterial counts determined during the course of
growth (up to 120 h) are presented in Fig. S2B and C. ****, P 0.001 (one-way analysis of variance
[ANOVA]/Tukey’s multiple-comparison test on log-transformed data).
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was assessed in medium containing cholesterol solubilized in hot dimethyl sulfoxide
(cholesterol-dimethyl sulfoxide [cholesterol:DMSO]). Strikingly, unlike the results seen
with cholesterol:EtOH, there was no signiﬁcant growth retardation in cholesterol:DMSO,
although a minor deﬁcit in strain ΔmftC growth in DMSO-containing medium in
comparison with the growth of wild-type strain was noted (Fig. 2B; see also Fig. S2B and
C). Thus, ethanol limits the growth of strain ΔmftC in cholesterol:EtOH.
Consequently, we assessed whether ethanol would also affect strain ΔmftC growth
in the presence of another carbon source such as propionate, acetate, or glycerol.
Supplementation of ethanol had no effect on strain ΔmftC growth in propionate (0.5%
[wt/vol]) or glycerol (0.2% [vol/vol]) but severely delayed strain ΔmftC growth in acetate
(0.5% [wt/vol]) in comparison with the growth of the wild-type strain (Fig. S2D to G).
Thus, we conclude that the effect of ethanol on strain ΔmftC growth depends on the
carbon source and that MFT and ethanol metabolism in M. smegmatis are linked.
The MFT gene cluster is required for ethanol assimilation in M. smegmatis.
Similar to M. marinum (25), M. smegmatis can utilize ethanol as the sole growth
substrate (Fig. 3A; see also Fig. S2C). To directly establish the role of MFT in ethanol
assimilation, the growth rates of mft mutants and the wild-type strain in ethanol were
compared. Strikingly, the mft mutants did not grow in ethanol (except for strain ΔmftE,
which presented delayed growth), whereas the wild-type strain as well as the ΔmftC-
Comp strains did grow in ethanol. In summary, the function of each mft gene affects
ethanol assimilation.
The inability of strain ΔmftC to grow in ethanol could be attributed to exacerbated
toxicity, because high concentrations of ethanol disrupt cell wall and membrane
integrity (26, 27). However, ethanol toxicity was not observed as a growth-limiting
factor in our study. The growth of strain ΔmftC remained unrestored even at the lowest
concentration of ethanol tested (Fig. S3A and B), and there was no ethanol-dependent
potentiation with respect to the effect of cell wall-damaging agents such as sodium
dodecyl sulfate (SDS) and lysozyme (Fig. S3C).
FIG 3 mft genes are essential for M. smegmatis growth and metabolism in ethanol. (A) Growth of the mft mutants,
unlike that of the wild type (WT), was impaired in medium containing ethanol (1% [vol/vol]) as the sole growth
substrate. (B) Disruption of mftC eliminated the growth of M. smegmatis in other primary alcohols. Data presented
in this panel were chosen to represent a time point (at 72 h) of the complete growth assay presented in Fig. S3.
(C and D) Acetaldehyde supplementation (0.001% [vol/vol]) partially restored the growth of strain ΔmftC in medium
containing (C) ethanol and (D) cholesterol:EtOH. Data are representative of results from two independent
experiments.
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To interrogate the functionality of MFT in catabolism of related substrates, the
growth rates of the wild-type strain and ΔmftC mutant in other primary alcohols were
compared. M. smegmatis grew in all primary alcohols examined (C2 to C6), except in
methanol, but with different growth rates under the conditions tested. In contrast,
disruption of mftC eliminated growth of M. smegmatis (Fig. 3B; see also Fig. S3D to I),
thereby strongly establishing the essential role of MFT in primary alcohol assimilation.
MFT is associated with ethanol oxidation in M. smegmatis. PQQ-dependent
ethanol assimilation involves alcohol and aldehyde dehydrogenases to oxidize ethanol
to acetic acid, a redox reaction, with acetaldehyde as a reaction intermediate (14–18).
Given the similarities between MFT and PQQ (3)—and the inability of the respective
biosynthetic mutants to grow in ethanol (17)—it has been proposed that MFT acts as
a redox cofactor to enable the function of alcohol dehydrogenase(s) (3, 13). Accord-
ingly, we assessed whether supplementation of acetaldehyde would rescue strain
ΔmftC growth in ethanol (probably by compensating for inactive MFT-dependent
alcohol dehydrogenase). Indeed, acetaldehyde (0.001% [vol/vol]) supplementation par-
tially restored the growth of strain ΔmftC in ethanol (Fig. 3C) as well as in cholesterol:
EtOH (Fig. 3D). Neither the mutant nor the wild-type strain grew in medium containing
only acetaldehyde (data not shown). Intriguingly, a similar acetaldehyde-dependent
growth correction has been reported to eliminate an ethanol-induced lag phase of
Saccharomyces cerevisiae via NAD replenishment by NADH oxidation (28–31). There-
fore, disruption of mft genes probably causes redox imbalance due to dysregulation/
dysfunction of MFT-associated alcohol dehydrogenase in M. smegmatis.
Ethanol alters the expression of genes associated with respiration and redox
homeostasis in M. smegmatis. Microarray-based global gene expression analysis was
performed to identify ethanol-inducible genes and to determine the cause of the
growth retardation of strain ΔmftC in ethanol and cholesterol:EtOH (Fig. 4A; see also
Table S2). Following ethanol treatment, genes associated with M. smegmatis respiration
(type I NADH:menaquinone oxidoreductases [nuo gene cluster]), acetate metabolism,
ectoine, B12-dependent glycerol dehydrogenase, and propane-diol metabolism, as well
as genes encoding several oxidoreductases, were upregulated in both the wild-type
strain and ΔmftC mutant. In contrast, genes associated with ATP synthase subunits
(atpB and atpE) and Sdh2 (sdhA, sdhB, sdhC, and sdhD), genes associated with nitrogen
metabolism (ureases and ammonium transporter), and genes rplL and MSMEG_1364
(50S ribosomal protein) were markedly downregulated in both strains after ethanol
treatment. In particular, the gene expression proﬁles of the ethanol-treated and
cholesterol:EtOH-treated strains were similar, suggesting that ethanol is preferred in the
hierarchy to induce speciﬁc transcriptional responses.
With regard to the ethanol-induced transcriptional response, whiB3 (MSMEG_1831)
and MSMEG_3644 (MerR family) were upregulated in strain ΔmftC in comparison with
the wild-type strain. Expression of MSMEG_6242, annotated as a glycerol/alcohol de-
hydrogenase, resulted in higher levels of accumulation in the wild-type strain than in
the mutant strains during ethanol treatment (Fig. 4A; see also Table S2). Assessment of
this transcriptional modulation by quantitative reverse transcription-PCR (qRT-PCR)-
based gene expression analysis revealed that the level of expression of MSMEG_6242
was signiﬁcantly higher in strain ΔmftC—both untreated and treated—than in the
wild-type strain (Fig. 4B). Taking the data together, transcriptional proﬁling indicated
that ethanol affects respiration and redox regulation and that the putative alcohol
dehydrogenase MSMEG_6242, requires MFT for its function.
MSMEG_6242 is a putative MFT-associated alcohol dehydrogenase. To validate
the role of MSMEG_6242 in ethanol assimilation in M. smegmatis, a deletion mutant was
constructed (Fig. S1) and phenotyped. Strikingly, the ΔMSMEG_6242 mutant failed to
grow in ethanol (Fig. 4C) as well as in cholesterol:EtOH (Fig. S4). However, this growth
impairment was corrected, as in the case of strain ΔmftC, by the supplementation of
acetaldehyde, thus conﬁrming the role of MSMEG_6242 in ethanol assimilation.
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In addition to MSMEG_6242, other oxidoreductase/dehydrogenase genes (MS-
MEG_1410, MSMEG_2687, and MSMEG_5866) have been predicted to be probable
MFT-associated nicotinoproteins, given their co-occurrence with mft genes in many
bacterial genomes (3, 13). The role of these dehydrogenases in ethanol assimilation was
analyzed in a genetic approach. While repeated attempts to isolate a viable MS-
MEG_2687 mutant strain were unsuccessful, mutant strains lacking MSMEG_5866 or
MSMEG_1410 were readily isolated (Fig. S1). Both of those mutant strains—unlike the
FIG 4 Comparative features of MFT-associated ethanol metabolism in M. smegmatis and M. marinum. An
ethanol-induced transcriptomic signature reveals the possible function of MFT and its dependent alcohol dehy-
drogenase. (A) Transcriptional proﬁle of ΔmftC and wild-type (WT) cells treated with ethanol and cholesterol:EtOH
for 4 h. The relative expression levels of the differentially expressed genes were compared between conditions or
bacterial strains. A gene cluster (MSMEG_6236 to MSMEG_6242) was upregulated only in the WT strain compared
with mutants treated with ethanol or cholesterol:EtOH. Intriguingly, the basal expression levels of these genes were
signiﬁcantly higher in untreated mutants (Table S2). (B) qRT-PCR-based quantiﬁcation of MSMEG_6242 transcript
levels in bacterial strains treated with the speciﬁed agents. Expression levels to normalized sigA (means standard
deviations) were calculated from data from three independent experiments performed in triplicates. An unpaired
t test with Welch’s correction was used to determine statistical signiﬁcance. **, P 0.01; *, P 0.05. (C) Functional
characterization of putative MFT-associated nicotinoproteins. Growth of strain ΔMSMEG_6242 in ethanol was
impaired, while strain ΔMSMEG_1410 and strain ΔMSMEG_5866 exhibited WT-like growth. (D) Growth of M.
marinum wild type (WTMm) and mutant ΔmftDMm in ethanol and cholesterol:EtOH. Consistent with the obtained M.
smegmatis results, the growth of strain ΔmftDMm was impaired. A representative growth curve from three
independent experiments is presented.
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ΔMSMEG_6242 and ΔmftC mutants—showed wild-type-like growth in ethanol and
cholesterol:EtOH (Fig. 4C; see also Fig. S4), suggesting their dispensability or redun-
dancy for ethanol assimilation. Given that the mutant’s growth phenotype can be used
as a criterion to establish functional association—along with prior bioinformatics
predictions (3)—MSMEG_6242 can be regarded as a putative MFT-dependent alcohol
dehydrogenase gene required for M. smegmatis growth in ethanol.
Note that no direct homolog of MSMEG_6242 is present in either M. marinum and M.
tuberculosis; however, only the latter grows poorly in ethanol (22, 25), suggesting
species-speciﬁc variations in MFT-associated growth and metabolism in ethanol. To
interrogate the relevance of MFT for the growth of M. marinum in the presence of
ethanol and cholesterol:EtOH, we disrupted mftD as a representative of the mft
genes (Table S1). Strikingly, the growth of M. marinum ΔmftD (ΔmftDMm) was
impaired in minimal medium containing ethanol (0.5% [vol/vol]) or cholesterol:
EtOH, thus emphasizing the signiﬁcance of MFT in ethanol assimilation as well as
establishing the functional existence of an MFT-associated but nonorthologous alter-
native for MSMEG_6242 in M. marinum (Fig. 4D).
Ethanol limits growth ofmftCmutant ofM. tuberculosis in cholesterol. UnlikeM.
smegmatis or M. marinum, M. tuberculosis has been found to grow poorly in ethanol
(22). To validate the function of MFT in M. tuberculosis, an in-frame deletion mutant
lackingmftC, here referred to as mftCMtb, was constructed (Fig. S1). As expected, strain
ΔmftCMtb exhibited a partial growth defect in medium containing cholesterol as the
sole carbon source, and a genetically complemented derivative, strain ΔmftCMtb-Comp,
showed restored growth in cholesterol:EtOH (Fig. 5A). Notably, the growth of strain
ΔmftCMtb was not severely retarded in cholesterol:DMSO (Fig. 5B). Because the M.
tuberculosis wild-type strain presented poor growth in ethanol, growth deﬁciency, if
any, in the mutant was undetectable (Fig. S5A). However, similar to the results seen
with M. smegmatis, acetaldehyde supplementation restored the growth of strain
ΔmftCMtb in cholesterol:EtOH to a level comparable to that seen with the wild-type
strain (Fig. 5A). Moreover, growth of strain ΔmftCMtb was unaffected in glycerol, or in
acetate, but was partly affected in propionate under conditions of ethanol repletion
(Fig. S5B to D). These results suggest that the function of mftC is conserved between M.
smegmatis and M. tuberculosis, regardless of their differential ability to grow in ethanol.
Transcriptional response of strain mftCMtb upon ethanol and cholesterol:
EtOH treatment. Microarray-based global gene expression proﬁling was performed to
investigate the impact of mftC deletion on the ethanol-induced M. tuberculosis tran-
scriptional response (Fig. 5C; see also Table S2). Comparisons of the responses of
wild-type M. tuberculosis and strain ΔmftCMtb revealed that most of the DosR regulon
genes were signiﬁcantly upregulated in the mutant, indicating a dysfunctional respi-
ratory or redox imbalance state of the ethanol-treated mutant. In contrast, genes
involved in cell wall biogenesis (kasA [1.6-fold]) and kasB [1.8-fold]) as well as genes
encoding iron-dependent enzymes (cysK2 [3.6-fold], furA [2.6-fold], and lytB2 [3.5-
fold]) were markedly downregulated in the mutant.
To examine the effect of mftC deletion on cholesterol utilization by M. tuberculosis,
the transcriptional responses of strain ΔmftCMtb treated with cholesterol:EtOH were
compared with those of the untreated control. Most notably, the genes required for
cholesterol catabolism—from sterol degradation (kstR2, fadE30, echA20, kshA, hsaA, and
hsaD) to propionate utilization (Rv1130, Rv1131, and icl1)—were upregulated in
cholesterol:EtOH-treated strain ΔmftCMtb. In contrast, approximately 2-fold reductions
in expression of genes involved in acetate metabolism (pdhA, pdhB, and pdhC) and in
respiration (nadA, nadB, and nadC and cydA) were observed in strain ΔmftCMtb. More-
over, the levels of gene expression of ethanol-treated and cholesterol:EtOH-treated M.
tuberculosis largely overlapped (Table S2 and S3).
Ethanol treatment does not impact redox and bioenergetics parameters in the
mftC mutant. Transcriptional analysis indicated that ethanol treatment affects the
respiration and redox status of the mftC mutant. We speculated that the cytosolic
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NADH/NAD ratio—which can reliably indicate redox status—is altered upon ethanol
treatment. Indeed, the NADH/NAD ratio was increased in the ethanol-treated wild-
type and mftCMtb strains (Fig. 6A) in comparison with the untreated culture. Intrigu-
ingly, there was no mutant-speciﬁc defect in recycling of NADH and NAD. In addition,
there were no differences in membrane potential (Fig. 6B) and in susceptibility to cell
wall-damaging agents (Fig. 6C) in both the wild-type and mftCMtb strains following
24 h of ethanol treatment (Fig. 6B and C). Furthermore, ethanol treatment did not
enhance the susceptibility of the wild-type and mutant strains to agents inducing redox
stress (1 mM cumene hydroperoxide [CHP] or tert-butyl hydroperoxide [tBHP]), sug-
gesting that MFT is not directly associated with cellular oxidative stress responses
(Fig. 6D). Likewise, there were no differences between the wild-type and mftCMtb
strains with respect to the oxygen consumption rate (OCR), as measured by the use of
FIG 5 Disruption of mftC impacts M. tuberculosis growth in cholesterol:EtOH. (A and B) Growth of strain
ΔmftCMtb and wild-type M. tuberculosis (WTMtb) in (A) cholesterol:EtOH and (B) cholesterol:DMSO. A
representative growth curve from two independent experiments is presented. (C) The transcriptional
response of strain ΔmftCMtb treated with cholesterol:EtOH largely mimics the ethanol-treated condition.
DosR-regulated genes were upregulated, while genes associated with respiration and redox homeostasis
were differentially regulated in strain ΔmftCMtb.
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an extracellular ﬂux analyzer (Fig. 6E and F). Most notably, similar ﬁndings were also
obtained with M. smegmatis strains (Fig. S6). Although transcriptional evidence sug-
gested a role for MFT in respiration/redox regulation, none of these results were
conﬁrmatory. Thus, MFT may be involved in a noncanonical redox mechanism in
mycobacteria.
DISCUSSION
Our results establish the signiﬁcance of MFT in mycobacterial metabolism of primary
alcohols complementing a range of biological functions documented for RiPPs. So far,
PQQ-dependent ethanol oxidation by acetic acid bacteria, which is exploited for the
industrial production of vinegar, has been well characterized (14–18). Intriguingly, the
M. smegmatis genome (but not the M. tuberculosis or M. marinum genomes) comprises
genes putatively involved in biosynthesis of PQQ and its dependent alcohol dehydro-
genases (MSMEG_3721 to MSMEG_3727) (3). However, the established genetic require-
ment of MFT for the growth of M. smegmatis in ethanol excludes the possibility of
overlapping functions of PQQ-dependent reactions under the in vitro conditions ex-
amined in the present study.
While MFT biosynthesis genes are conserved, the numbers of predicted MFT-
associated nicotinoproteins encoded in mycobacterial genomes differ greatly and
FIG 6 Disruption ofmftC does not impact ethanol-induced changes in redox status and basal respiratory
capacity. (A) Ethanol treatment of wild-type M. tuberculosis (WT) and strain ΔmftCMtb for 24 h altered the
NADH/NAD ratio but was independent of mftC function. (B) Membrane potential was unaltered in the
presence of ethanol (1% [vol/vol]). Cells treated with 20 M carbonyl cyanide m-chlorophenyl hydrazine
(CCCP) for 30 min were used as a positive control. ****, P 0.001 (two-way ANOVA/Tukey’s multiple-
comparison test). (C and D) Notably, strain ΔmftCMtb was not increasingly susceptible to (C) cell
wall-damaging agents (0.015% SDS or 2.5 mg/ml lysozyme) or (D) oxidative-stress-inducing agents (1 mM
CHP or 1 mM tBHP) in the presence of ethanol (1% [vol/vol]). ns, not signiﬁcant (one-way ANOVA/Tukey’s
multiple-comparison test on log-transformed data). (E and F) No difference in OCR, measured using an
Agilent Seahorse XFp analyzer, was noted. Time points for the addition of compounds are indicated by
vertical dotted lines. The ﬁnal well concentrations were 1 mM (glucose), 1% (ethanol), and 5 M (CCCP).
The OCR data points are representative of the average OCR during 4 min of continuous measurement in
the transient microchamber. Standard deviations were calculated from the OCR measurements taken
from three replicate wells by the use of Wave Desktop 2.4.0 software. Pooled data from three indepen-
dent experiments showed no statistically signiﬁcant differences (two-way ANOVA/Tukey’s multiple-
comparison test) between the conditions.
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could impact the ethanol assimilatory capacity—complete or partial—of each
mycobacterial species. For instance, the lack of a homolog of MSMEG_6242 in M.
tuberculosis could account for its poor growth in ethanol. Yet M. marinum, lacking
a direct homolog of MSMEG_6242, was found to exhibit sustained growth in
ethanol, probably owing to the functionality of other MFT-associated dehydrogenases.
Moreover, the proposition of a functional relationship between MFT and MSMEG_6242
is solely based on the mutant’s shared phenotypes and on prior bioinformatics pre-
diction (3) and thus requires further biochemical conﬁrmation. Nevertheless, the es-
tablished role of MSMEG_6242 in ethanol assimilation adds to the functional diversity
of this enzyme in methylotrophy (32, 33) and in glycerol metabolism and as a target for
posttranscriptional/posttranslational regulation and S-mycothiolation (34–36). There-
fore, MSMEG_6242, and probably also MFT, is likely to function at the crossroads of
regulation, metabolism, and growth inM. smegmatis. In contrast, ethanol metabolism—
and related MFT function—appears to be irrelevant forM. tuberculosis, perhaps because
the status of availability of these volatile compounds with hydroxy groups during
infection is ambiguous. Nonetheless, ethanol, as a poor growth substrate for M.
tuberculosis, has been demonstrated to alter the cellular state, with NADH accumulation
corresponding to the increase in expression of DosR regulon genes (37), mimicking
ascorbate treatment (38) and hypoxia adaptation (39). Accordingly, an inability to
support active growth is not a strong criterion to predict the impact of a substrate on
cellular respiration. Therefore, it is tempting to speculate that a similar poor growth
substrate, particularly under nutrient/oxygen-deprived conditions (40, 41), could con-
tribute to respiratory ﬂexibility and, in turn, prolong the survival of M. tuberculosis.
Mycobacterial respiration under hostile conditions requires utilization of different
electron donors and acceptors, the diversity of which is not completely known (19, 41).
To this end, the proposed function of MFT as an electron carrier involved in redox
exchange with its nicotinoprotein partners gains signiﬁcance (3). The present study
demonstrated that ethanol-induced transcriptional signatures exhibit strong associa-
tions between MFT function and redox homeostasis/respiration. Notably, loss of func-
tion of mftC resulted in multifold increases in expression of the DosR regulon genes in
ethanol-treated M. tuberculosis. The DosR regulon expression is triggered by the redox
sensor DosS in response to a reduced menaquinone pool of the respiratory chain (38,
42). Furthermore, MftC contains at least two iron-sulfur clusters with an intrinsic ability
to regulate the redox state of bacterial cells (3, 5, 6, 43). This notion is further supported
by the identiﬁcation of mft genes as part of a transcriptional network, which are
differentially regulated in response to (or in compensation for) the loss of function of
whiB4, which recognizes the intracellular redox signals in M. tuberculosis (44). None-
theless, we noted that the M. tuberculosis strain lacking mftC function was neither
hypersusceptible to redox stressors nor impaired in recycling nicotinamide cofactors in
comparison with the wild-type strain in the presence of ethanol. One possible reason
for this lack of differences in NADH/NAD recycling could be that the MFT-associated
nicotinoprotein probably does not rely on cofactor exchange but instead uses MFT as
an external redox partner and a nonexchangeable NAD for multiple turnover, as
suggested earlier (3, 13). Alternatively, the functions of MFT are likely analogous to
those of PQQ, which acts as a redox couple (PQQ/PQQH2) during alcohol oxidation in
quinoprotein dehydrogenase (14, 18, 45–47). This PQQ-dependent enzyme is known to
donate electrons to c-type cytochromes or directly to ubiquinone instead of using
NAD or NADP as an electron acceptor (48). Therefore, understanding the nature of
MFT-associated redox chemistry (with its nicotinoprotein partners) and of its impact on
mycobacterial cellular metabolism is crucial and the subject of ongoing investigation.
Intriguingly, we found that disruption of mft genes profoundly impaired the ability
of mycobacterial species to assimilate cholesterol in the presence of ethanol. Grifﬁn et
al. (20) pioneered the identiﬁcation of essential genes for cholesterol catabolism by
comparing mutant pools grown under glycerol:EtOH and cholesterol:EtOH conditions.
Here we found that, remarkably, ethanol selectively compromised the ability of strain
ΔmftC to assimilate cholesterol, but not glycerol, which likely inﬂuenced the essentiality
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prediction of MFT genes. Similarly, Nazarova et al. (21) demonstrated that disruption of
mft genes alleviated the growth defect of M. tuberculosis strain Δicl1::hyg in the
presence of cholesterol:EtOH and a carbohydrate. We propose that, under such con-
ditions, ethanol-derived suboptimal cholesterol catabolism (by partial degradation of
the carbon) in strain ΔmftC reduces propionyl-coenzyme A (propionyl-CoA) ﬂux and
consequently methylcitrate toxicity, enabling the growth of strain Δicl1::hyg. Although
the effect of ethanol was obvious with additional results obtained from M. smegmatis
and M. marinum, the possibility of an impact of other constituents of media on growth
cannot be precluded. Nevertheless, in addition to the results seen with cholesterol, the
rate of growth of M. smegmatis in acetate was also restricted by ethanol and was
reminiscent of catabolite repression. This effect was, however, less pronounced in M.
tuberculosis, implying species-speciﬁc differences in potential mechanisms of ethanol-
induced inhibition of cholesterol metabolism. The mechanisms underlying ethanol-
induced growth stasis/impairment are multifactorial, as observed in other bacterial
systems: ethanol (i) impairs the regeneration of NADH/NAD (29–31); (ii) affects the
uptake of acetate (16, 49–51); and (iii) suppresses the genes required for acetate
assimilation and metabolic turnover of acetyl-CoA (52–54). Although these factors may
still be relevant in the case of strain ΔmftC growth impairment in acetate or cholesterol:
EtOH, our transcriptomic analysis suggests that the extent of ethanol-induced growth
impairment is probably owed to compounded and yet species-speciﬁc effects of redox
imbalance and altered bioenergetics.
Our genetic analysis adds to the expanding knowledge about MFT biosynthesis (3,
5–9) in the context of ethanol metabolism. However, the inferred functional discor-
dance of the data resulting from analyses of the mftE gene was unexpected, despite its
well-recognized signiﬁcance in MFT maturation (7–9). Nevertheless, the growth per-
missiveness of strain ΔmftE in ethanol could have been the result of residual functions
of an end metabolite(s) lacking an MftE-mediated modiﬁcation(s) or of other compen-
satory gene functions. Complementing the ongoing efforts (5–9) in elucidating the
signiﬁcance of mftE and other mft genes in the structural/functional diversity of
MftA-derived metabolites, future studies should directly investigate nonpathogenic M.
smegmatis strain as a more appropriate natural host with fully functional associated
metabolic pathways.
In conclusion, we identiﬁed a previously unknown function of MFT, a peptide-
derived cofactor, in ethanol assimilation in mycobacteria. MFT is most likely associated
with several other biochemical processes, because it is predicted to act as a redox
cofactor for other dehydrogenases whose functions were shown here to be unrelated
to ethanol metabolism. Although the role of MFT inM. tuberculosis survival, persistence,
and pathogenesis cannot be reliably predicted, the complete loss of MFT biosynthesis
in M. leprae (3) and species-speciﬁc variations in genes encoding MFT-associated
dehydrogenases suggest, at the least, a selective advantage for the retention of MFT in
mycobacterial species to inhabit diverse ecological niches.
MATERIALS AND METHODS
Bacteria, media, and growth conditions. Strains used in this study are listed in Table S1 in the
supplemental material. Escherichia coli DH5 was propagated in Luria-Bertani (LB) medium at 37°C or on LB
agar plates containing no or appropriate antibiotics. Mycobacterial strains were propagated in Middlebrook
7H9 broth (Difco) supplemented with albumin-dextrose-catalase enrichment (Becton, Dickinson), 0.2% glyc-
erol, and 0.05% Tyloxapol at 37°C with agitation/rotation (100 rpm) or on Middlebrook 7H11 agar containing
10% (vol/vol) oleic acid-albumin-dextrose-catalase enrichment (Becton, Dickinson) at 37°C. All other chemicals
were from Sigma-Aldrich/Fisher Scientiﬁc unless otherwise speciﬁed.
Carbon utilization assays were performed using minimal medium as described earlier (20). Choles-
terol (0.01%) was solubilized in 0.5% hot ethanol or 1% hot DMSO. Other carbon sources tested were
sodium acetate (0.5%), sodium propionate (0.1% or 0.5%), ethanol (0.01% to 1%), methanol (0.5%),
propan-1-ol (0.1%), butan-1-ol (0.1%), pentan-1-ol (0.01%), and hexan-1-ol (0.1%). Wherever appropriate,
0.001% acetaldehyde was supplemented. To determine susceptibility to redox stressors, bacterial cells at
the log phase of growth were treated with 1 mM CHP or tBHP for 1 h (M. tuberculosis) and 2 h (M.
smegmatis) under conditions of ethanol repletion at 37°C. To assess the impact of cell wall-damaging
agents, the bacterial cells at the log phase of growth were treated with 0.015% of SDS or with 2.5 mg/ml
lysozyme for 2 h at 37°C in the presence of 1% ethanol. The recovered bacterial CFU were enumerated.
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Construction of mutants. Allelic exchange mutants were constructed by two-step selection using
the p2NIL/pGOAL system (55). Bacterial genotyping was done by PCR and Southern blotting. Genetic
complementation studies used integration plasmid pMCpAINT (56). The details of PCR oligonucleotides
and suicide plasmids are provided in Table S1.
RNA extraction and microarray analysis. Bacterial strains were treated with 1% ethanol or
cholesterol:EtOH (0.01% cholesterol–1% ethanol) for 4 h (M. smegmatis) or 24 h (M. tuberculosis). RNA was
extracted with TRIzol reagent (Invitrogen). Cell lysis was achieved through three cycles of bead beating
in a FastPrep-24 instrument (MP) at 4.5 m/s for 30 s. RNA was prepared using a Turbo DNA-free kit
(Ambion), and RNA concentrations and quality were determined with a NanoDrop ND-1000 spectro-
photometer and an Agilent 2100 Bioanalyzer, respectively. Quantitative PCR (qPCR) was performed with
Fast SYBR green Master Mix kit (Applied Biosystems).
Microarray experiments were performed as dual-color hybridizations on custom M. smegmatis
4-by-44K (Agilent-017184/expression) and on custom 8-by-60K M. bovis BCG—M. tuberculosis H37Rv M.
tuberculosis V3 (Agilent-035148/multipack) arrays. To compensate for dye-speciﬁc effects, dye-reversal
color-swap hybridizations were applied. Total RNA labeling and ampliﬁcation were performed using a
Quick Amp gene expression labeling kit (Agilent Technologies) and a 5:1 mixture of FullSpectrum
MultiStart T7 primer (BioCat GmbH) with oligo(dT)-T7 primer (Agilent Technologies). After precipitation,
puriﬁcation, and quantiﬁcation, 0.75-g volumes of both Cy-labeled cRNAs were fragmented and
hybridized to Agilent-035148 or 1.25 g of each labeled cRNA was used with Agilent-017184. Scanning
of microarrays was performed with either 3-m resolution and 20 bits (8 by 60K) or an extended dynamic
range and 5-m resolution and 16 bits (4 by 44K) using a G2565CA high-resolution laser microarray
scanner (Agilent Technologies). Microarray image data were processed using Image Analysis/Feature
Extraction G2567AA v. A.11.5.1.1 software and default settings and the GE2_1105_Oct12 extraction
protocol. The extracted MAGE-ML ﬁles were analyzed with Rosetta Resolver Biosoftware, Build 7.2.2
SP1.31 (Rosetta Biosoftware). Ratio proﬁles comprising single hybridizations were combined in an
error-weighted fashion to create ratio experiments. A 1.5-fold change expression cutoff value for ratio
experiments was applied together with dye-swapped ratio proﬁles, rendering the microarray analysis
data highly signiﬁcant (P 0.01), robust, and reproducible (57). Alternatively, the extracted raw data ﬁles
(.txt) were analyzed using R and the associated BioConductor limma R package (58).
Measurement of NAD/NADH levels and membrane potential. Bacterial cells were subjected to
ethanol treatment for 4 h (M. smegmatis) or 24 h (M. tuberculosis). The NAD and NADH concentrations
were determined using a FluroNAD/NADH detection kit (Cell Technology). The membrane potential ofM.
smegmatis strains was determined after incubation with DiCO2 ﬂuorescent dye (3 mM) for 30 min and
was further analyzed on a BD ﬂuorescence-activated cell sorter (FACS) LSRII instrument, whereas the
membrane potential of M. tuberculosis strains was measured as previously reported (59) with some
modiﬁcations. Samples were transferred into clear-bottom 96-well microtiter plates and centrifuged at
3,500 g for 10 min. DiOC2 (15 M) was then added to each well and incubated for 20 min at room
temperature, followed by ﬁxation with 4% formaldehyde for an additional 60 min. Subsequently, samples
were washed with fresh 7H9 medium to remove extracellular dye. A SpectraMax M5 spectroﬂuorimeter
(Molecular Devices) was used to measure green ﬂuorescence (488-nm wavelength/530-nm wavelength)
and shifts to red ﬂuorescence (488-nm wavelength/610-nm wavelength). Membrane potential was
determined as the ratio of red ﬂuorescence to green ﬂuorescence. Untreated and carbonyl cyanide
m-chlorophenyl hydrazine (CCCP)-treated cells were included as controls. Each condition was measured
in triplicate, and each experiment was performed at least twice.
Extracellular ﬂux analysis. OCR values were measured as described earlier (60), with some modi-
ﬁcations, using unbuffered (pH 7.35) minimal medium (M. smegmatis) and Middlebrook 7H9 medium (M.
tuberculosis) free from any carbon sources.
For the M. smegmatis experiments, a culture in the mid-log phase of growth (optical density at 600
nm [OD600] of 0.8) was starved for 6 h in carbon source-free minimal medium containing 0.01% tyloxapol.
Then, 2 105 to 4 105 cells/well were added to a Cell-Tak (Corning)-coated XF 96 cell culture
microplate and were analyzed using an Agilent Seahorse XFe96 analyzer. OCR values were measured for
about 21 min before the addition of preloaded ethanol (1%) or of medium through injection ports of the
sensor cartridge. Finally, 5 mM CCCP was added to the wells and the measurement was continued for
another 21 min.
For the M. tuberculosis experiments, a culture in the log phase of growth (OD600 of 0.6 to 0.8) was
starved for 18 to 24 h in carbon source-free 7H9 medium containing 0.01% tyloxapol. Subsequently,
about 5 105 cells/well were added to a Cell-Tak-coated XFp miniplate and analyzed using an Agilent
Seahorse XFp analyzer. The assay conditions were similar to those described for M. smegmatis.
Statistical analysis. GraphPad Prism 7.03 software was used for statistical analyses. P values of less
than 0.05 were considered statistically signiﬁcant.
Data availability. Microarray data are available from the NCBI GEO database under accession no.
GSE121398.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
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